Generic Arimidex is used for treating breast cancer in women who have been through menopause, including women with disease progression after tamoxifen therapy.
Generic Cytoxan is used for treating certain types of the following cancers: lymphoma, multiple myeloma, leukemia, mycosis fungoides, neuroblastoma, ovarian cancer, eye cancer and breast cancer. It is usually used in combination with other medicines. It may also be used to treat certain kidney problems (nephrotic syndrome) in children.
Generic Droxia is used for reducing the number of painful episodes and blood transfusions needed by adults with sickle cell anemia experiencing recurrent episodes associated with moderate to severe pain.
Generic Eulexin is an antiandrogen. It works in the body to prevent the actions of androgens (male hormones). It is used in the treatment of prostate cancer.
Generic VePesid is used for treating patients with lung cancer and recurrent testicular tumors. It is used in combination with other cancer medications. VePesid is an antineoplastic. It works by stopping the tumor cells from dividing (mitosis), which prevents the spread of certain types of cancer.
Prostate cancer drug Abiraterone set for approval in England and Wales but not ... - Daily Mail
Daily MailProstate cancer drug Abiraterone set for approval in England and Wales but not .
Pfizer drug effective in rare children's cancers - Reuters UK
TheStreet.
Genetic breast cancer 'map' drawn - The Press Association
Daily MailGenetic breast cancer 'map' drawnThe Press AssociationA genetic 'map' of breast cancer has been drawn, revealing the varied landscape of the disease in more detail than ever before.
Aveo kidney cancer drug more tolerated than Nexavar - Reuters UK
XconomyAveo kidney cancer drug more tolerated than NexavarReuters UKBy Bill Berkrot (Reuters) - Patients taking a kidney cancer drug being developed by Aveo Pharmaceuticals Inc were half as likely to need a break from the medication due to side effects than those on the widely used medicine Nexavar, according to data .
Cancer death rates fall among 50-somethings - The Guardian
The GuardianCancer death rates fall among 50-somethingsThe GuardianDeaths from cancer among 50-somethings have fallen to their lowest level in 40 years, thanks to better diagnosis, fewer people smoking and new drugs improving patients' chances of survival.
